Medifast, Inc.
MED
$13.64
-$0.45-3.19%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -37.70% | -40.58% | -43.09% | -49.93% | -43.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -37.70% | -40.58% | -43.09% | -49.93% | -43.36% |
| Cost of Revenue | -37.99% | -41.04% | -47.21% | -53.75% | -45.71% |
| Gross Profit | -37.60% | -40.42% | -41.42% | -48.34% | -42.48% |
| SG&A Expenses | -34.44% | -31.95% | -23.81% | -39.00% | -34.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.12% | -34.37% | -31.48% | -43.99% | -37.65% |
| Operating Income | -91.83% | -91.74% | -120.35% | -82.73% | -80.63% |
| Income Before Tax | -86.99% | -94.06% | -127.23% | -78.28% | -69.75% |
| Income Tax Expenses | -87.42% | -86.86% | -128.24% | -75.53% | -36.04% |
| Earnings from Continuing Operations | -86.73% | -95.12% | -126.93% | -79.19% | -77.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -86.73% | -95.12% | -126.93% | -79.19% | -77.24% |
| EBIT | -91.83% | -91.74% | -120.35% | -82.73% | -80.63% |
| EBITDA | -67.63% | -92.34% | -111.43% | -77.87% | -74.81% |
| EPS Basic | -86.79% | -95.14% | -126.81% | -79.28% | -77.20% |
| Normalized Basic EPS | -87.04% | -94.08% | -127.10% | -75.94% | -77.98% |
| EPS Diluted | -87.20% | -95.28% | -127.08% | -79.29% | -77.29% |
| Normalized Diluted EPS | -87.04% | -94.08% | -127.18% | -75.97% | -77.91% |
| Average Basic Shares Outstanding | 0.41% | 0.41% | 0.45% | 0.41% | -0.18% |
| Average Diluted Shares Outstanding | 0.44% | 0.35% | 0.18% | 0.54% | -0.53% |
| Dividend Per Share | -- | -- | -- | -- | -100.00% |
| Payout Ratio | -1.00% | -1.00% | -1.00% | -0.82% | 3.41% |
